Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 02 - 15 save search
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
NKTX | $5.76 -0.69% -0.69% 450K
|
Health Technology
|
| O: 1.9%
H: 4.42%
C: 2.94%
CRSP M | $55.3 -1.46% -1.48% 1.2M
|
Health Technology
|
| O: 2.37%
H: 2.27%
C: 1.62%
financial results therapeutics crispr report results
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
SANA | $4.7 -4.47% -4.68% 640K
|
|
| O: 2.07%
H: 4.63%
C: 3.76%
SGTX | $0.72 -0.04% 72K
|
Health Technology
|
| O: -0.62%
H: 5.62%
C: 1.87%
PPG M | $130.73 -2.75% 0.0% 1M
|
Process Industries
|
| O: 1.67%
H: 0.76%
C: -0.09%
MCRB | $5.5 -3.0% -3.09% 760K
|
Health Technology
|
| O: 1.27%
H: 7.38%
C: 5.5%
RUBY M | $0.2857 -2.79% -4.81% 560K
|
Health Technology
|
| O: 2.87%
H: 3.49%
C: 0.52%
MRNA M | $173.27 -1.75% -1.78% 2.8M
|
Health Technology
|
| O: 0.01%
H: 7.33%
C: 6.06%
KLDO | $0.29 0%
|
Health Technology
|
| O: -0.64%
H: 4.49%
C: 3.85%
FHTX A | $8.515 -0.41% -0.41% 20K
|
Health Technology
|
| O: 3.91%
H: 0.0%
C: -4.07%
EVLO | $0.91 6.44% 6.05% 200K
|
Health Technology
|
| O: 0.77%
H: 8.38%
C: 2.28%
DNLI | $31.71 -2.94% -3.03% 520K
|
Health Technology
|
| O: 1.58%
H: 3.53%
C: 0.59%
CDAK 4 | $0.775 3.33% 3.23% 690K
|
Health Technology
|
| O: 2.7%
H: 4.66%
C: 4.05%
AXLA | $0.7205 9.4% 8.59% 440K
|
Health Technology
|
| O: 2.99%
H: 3.49%
C: 3.49%
ces grant granted
U.S. Food and Drug Administration (FDA) Accepts Mirati Therapeutics' New Drug Application for Adagrasib as Treatment of Previously Treated KRASG12C-Mutated Non-Small Cell Lung Cancer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
MRTX | $52.55 -3.15% -3.25% 1M
|
Health Technology
|
| O: 1.42%
H: 5.52%
C: 4.35%
krasg12 new drug treatment fda application drug therapeutics cel food lung cancer cancer fda acceptance
CENTENE OREGON HEALTH PLAN ACHIEVES NCQA ACCREDITATION
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CNC | $71.01 -2.15% 0.34% 5.1M
|
Health Services
|
| O: 1.34%
H: 1.37%
C: 1.17%
health
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
ADPT | $9.85 0.0% 990K
|
Commercial Services
|
| O: 3.0%
H: 1.86%
C: -2.78%
financial results report results biotech iot
How far we’ve come part 3 – animal genomics
Published: 2022-02-15 (Crawled : 23:00) - pacb.com
PACB | $11.59 -3.42% -3.54% 4.6M
|
Health Technology
|
| O: -9.05%
H: 15.56%
C: 14.78%
genomics genomic
Omnicom Group Inc. Declares Dividend
Published: 2022-02-15 (Crawled : 23:00) - omnicomgroup.com
OMC | $91.71 -0.13% 0.59% 2.5M
|
Commercial Services
|
| O: -1.09%
H: 1.86%
C: 1.01%
group
Celularity Receives Orphan Drug Designation from U.S. FDA for its NK Cell Therapy CYNK-101 in Development for the First-Line Treatment of Advanced HER2/neu Positive Gastric and Gastroesophageal Junction Cancers
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CELU | $0.9604 3.05% 2.96% 390K
|
|
| O: 4.73%
H: 5.21%
C: 3.47%
cynk-101 treatment fda drug drug designation cel orphan drug positive therapy cancer designation her2-
Nexstar Media Group Names Jay Howell Vice President and General Manager of its Broadcasting and Digital Operations in Las Vegas, Nevada
Published: 2022-02-15 (Crawled : 23:00) - nexstar.tv
NXST 4 | $209.33 -1.61% -1.63% 460K
|
Consumer Services
|
| O: -0.96%
H: 1.36%
C: 0.47%
star media broadcast group
Champions Oncology Announces a Partnership with GigaMune to Discover Novel Tumor-Reactive T Cell Receptors
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
CSBR | $4.3 0.0% 4.3K
|
Health Technology
|
| O: 2.2%
H: 8.09%
C: 4.18%
react partnership ces cel active t-cell
LINGO MEDIA ENGAGES GENERATION IACP INC. FOR MARKET MAKING SERVICES
Published: 2022-02-15 (Crawled : 23:00) - lingomedia.com
LMDCF | $0.0578
|
Consumer Services
| Email alert
Add to watchlist
ces media services
Coherus Names Paul Reider Chief Commercial Officer
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
ABBV | News | $145.2 0.25% 0.0% 6.5M
|
Health Technology
|
| O: 0.24%
H: 1.47%
C: 0.98%
CHRS | $8.5 -5.13% -5.41% 750K
|
Health Technology
|
| O: 0.77%
H: 2.82%
C: 0.53%
AMGN | $245.12 -0.57% -0.58% 3.1M
|
Health Technology
|
| O: 0.33%
H: 0.52%
C: -0.47%
commercialization
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
TWST | News | $25.3 -18.12% -22.13% 3.3M
|
Health Technology
|
| O: 2.82%
H: 5.53%
C: 5.16%
offering ces bioscience
Season two of the Inflection Points podcast arrives!
Published: 2022-02-15 (Crawled : 23:00) - extremenetworks.com
EXTR | $19.29 2.55% 2.49% 1.7M
|
Electronic Technology
|
| O: -1.91%
H: 2.39%
C: 2.19%
pod
Cumulus Wilmington’s WGNI-FM, WMNX-FM and WWQQ-FM Raise $60,975 in 26-Hour Radiothon for St. Jude Children’s Research Hospital
Published: 2022-02-15 (Crawled : 23:00) - cumulusmedia.com
CMLS | $6.75 -0.74% -0.74% 150K
|
Consumer Services
|
| O: -1.17%
H: 2.37%
C: 1.19%
research children iot
BiondVax to Present at BIO CEO & Investor Conference
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
BVXV | $2.66 2.7% 2.63% 88K
|
Health Technology
|
| O: -0.78%
H: 5.47%
C: 3.91%
ceo conference
Jazz Pharmaceuticals to Report 2021 Fourth Quarter and Full Year Financial Results on March 1, 2022
Published: 2022-02-15 (Crawled : 23:00) - biospace.com/
JAZZ S | $155.67 -0.47% -0.47% 400K
|
Health Technology
|
| O: 0.08%
H: 2.83%
C: 1.44%
als financial results report results
TC Biopharm Announces Closing of $17.5 Million Initial Public Offering
Published: 2022-02-15 (Crawled : 23:00) - prnewswire.com
TCBP | $5.62 4.07% 3.91% 780K
|
|
| O: -1.73%
H: 1.76%
C: -1.18%
offering ces publication
RAVE Restaurant Group, Inc. Reports Extinguishment of Convertible Notes
Published: 2022-02-15 (Crawled : 23:00) - prnewswire.com
RAVE 4 | $1.6 -9.03% 32K
|
Consumer Services
|
| O: 1.67%
H: 0.9%
C: 0.0%
report restaurant group
Heritage Announces Fourth Quarter 2021 Earnings Dates
Published: 2022-02-15 (Crawled : 23:00) - prnewswire.com
HRTG | $2.31 -10.47% 0.0% 140K
|
Finance
|
| O: -0.53%
H: 1.07%
C: 0.18%
ces
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.